<DOC>
	<DOC>NCT03058432</DOC>
	<brief_summary>Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma</brief_summary>
	<brief_title>Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma</brief_title>
	<detailed_description>To evaluate concurrent chemotherapy for elderly patients with locoregionally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<criteria>Previously untreated and histologically confirmed locoregionally advanced nasopharyngeal carcinoma A history of another invasive cancer, prior RT to the head and neck area, prior cytotoxic chemotherapy or antiEGFR therapy or the presence of any serious medical conditions,supposed to live less than 6 months.</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>